QHSLab, Inc. Files 8-K: Regulation FD & Financials

Ticker: USAQ · Form: 8-K · Filed: Nov 14, 2024 · CIK: 856984

Sentiment: neutral

Topics: regulation-fd, financials, corporate-history

TL;DR

QHSLab filed an 8-K on Nov 13, 2024, covering Reg FD and financials. Formerly USA EQUITIES CORP.

AI Summary

On November 13, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31st. Its business and mailing address is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.

Why It Matters

This 8-K filing provides crucial updates on QHSLab, Inc.'s regulatory disclosures and financial reporting, offering insights into the company's current operational and compliance status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure and financial exhibits, not indicating any immediate material adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for QHSLab, Inc.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing occurred on November 13, 2024.

What are some of the former names of QHSLab, Inc. mentioned in the filing?

The filing mentions that QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.

In which state is QHSLab, Inc. incorporated?

QHSLab, Inc. is incorporated in Nevada.

What is the business and mailing address for QHSLab, Inc.?

The business and mailing address for QHSLab, Inc. is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.

Filing Stats: 665 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-11-14 08:13:04

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 14, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing